PAR paradigm biopharmaceuticals limited..

Ann: Loyalty and Piggyback Options Program, page-543

  1. 1,230 Posts.
    lightbulb Created with Sketch. 276
    Yes. Less dilutive has been used before. There aim is non dilutive and or less dilutive but have never ruled out anything.
    I think the peer review publications are important for potential partners and the market in general. In fact we may be waiting on that to trigger a deal. May be more of a catalyst than you think....
    Last edited by goldmad: 28/02/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
31.5¢
Change
-0.010(3.08%)
Mkt cap ! $124.6M
Open High Low Value Volume
33.0¢ 35.0¢ 31.5¢ $418.4K 1.266M

Buyers (Bids)

No. Vol. Price($)
1 92499 31.5¢
 

Sellers (Offers)

Price($) Vol. No.
32.0¢ 63097 1
View Market Depth
Last trade - 16.10pm 25/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.